Integrated Wealth Concepts’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-13,931
| Closed | -$916K | – | 1792 |
|
2024
Q4 | $916K | Sell |
13,931
-1,162
| -8% | -$76.4K | 0.01% | 858 |
|
2024
Q3 | $1.07M | Sell |
15,093
-10
| -0.1% | -$706 | 0.01% | 777 |
|
2024
Q2 | $1M | Buy |
15,103
+1,290
| +9% | +$85.6K | 0.01% | 759 |
|
2024
Q1 | $938K | Sell |
13,813
-56
| -0.4% | -$3.8K | 0.01% | 779 |
|
2023
Q4 | $857K | Buy |
13,869
+270
| +2% | +$16.7K | 0.01% | 793 |
|
2023
Q3 | $802K | Sell |
13,599
-162
| -1% | -$9.56K | 0.01% | 780 |
|
2023
Q2 | $821K | Sell |
13,761
-1,587
| -10% | -$94.7K | 0.01% | 758 |
|
2023
Q1 | $897K | Sell |
15,348
-60
| -0.4% | -$3.51K | 0.02% | 653 |
|
2022
Q4 | $956K | Buy |
15,408
+675
| +5% | +$41.9K | 0.03% | 485 |
|
2022
Q3 | $833K | Buy |
14,733
+435
| +3% | +$24.6K | 0.03% | 462 |
|
2022
Q2 | $913K | Sell |
14,298
-660
| -4% | -$42.1K | 0.03% | 443 |
|
2022
Q1 | $968K | Buy |
14,958
+447
| +3% | +$28.9K | 0.03% | 402 |
|
2021
Q4 | $966K | Buy |
14,511
+603
| +4% | +$40.1K | 0.03% | 429 |
|
2021
Q3 | $849K | Buy |
+13,908
| New | +$849K | 0.03% | 440 |
|